AstraZeneca vaccine safe to use while potential rare effects probed: WHO
Tweet
Share
E-mail
FILE PHOTO: Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
GENEVA (Reuters) - The AstraZeneca COVID-19 vaccine is still recommended for use while studies continue to examine any potential link to "very rare" side effects including blood clots, a senior World Health Organization (WHO) official said on Friday.
"The position stands that the benefits outweigh the risks," Mariangela Simao, WHO assistant director-general, told a news conference. "It's being investigated, a potential link to a very rare side-event...which would happen (to) one in a million, is still being investigated by WHO and also by the European Medicines Agency and other regulatory agencies."
(Reporting by Stephanie Nebehay and Emma Farge; editing by Brenna Hughes-Neghaiwi)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roche obesity drug shows 15.5% weight loss in diabetes trial
- Capri stock surges on potential buyer interest report
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
